Globally, Cambrex offers a variety of technology-driven products and services that accelerate the development of small molecule therapeutics from custom development to commercial manufacturing, including advanced chemical synthesis, enzymatic biotransformations, high potency APIs, high energy chemistry, controlled substances and formulation of finished dosage form products.
In this webinar, we examine how Cambrex works with large, mid-size, emerging and niche pharmaceutical companies to meet their changing small molecule needs and bring their products to market quickly.
Dr. Matthew Moorcroft, VP of Global Marketing, Cambrex
Bjarne Sandberg, Managing Director, Cambrex Karlskoga
Joe Nettleton VP, Operations and Site Director, Cambrex Charles City